Making Medicines affordable.

News Room

Press Releases

Media Kit

Press Releases

2004

2004/11/18

The 2004 edition of the EGA Award has been granted jointly to Commissioners Erkki Liikanen and David Byrne for their role in establishing and supporting the G10 High Level Group on Medicines initiative.

2004/11/10

The EGA elected Mr Emile Loof, president of Pharmachemie BV of the Netherlands, as president of the EGA for 2004-2006. Mr Loof was elected on 9 November, immediately following the 10th Annual EGA Conference in Amsterdam, where government and industry representatives showed evidence of the benefits generated from measures promoting generic medicines in the EU.

2004/11/02

The EGA welcomes the European Commission’s proposed Regulation on Compulsory Licensing which will allow the manufacture and export of generic versions of patented medicines to developing countries facing important health needs.

2004/10/29

Greg Perry, Director General of EGA, today received the Golden Cross of Merit of the Republic of Poland in recognition of exceptional services to Poland in relation to the country’s accession to the European Union.

2004/09/29

The EGA welcomes the European Commission's draft Regulation on paediatric medicines, while urging improvements to the proposal to maximise benefits to children.

2004/09/01

The EGA has revised its logo, incorporating the image of a "capsule" to make the EGA more instantly recognisable as an organisation dedicated to the provision of affordable medicines.

2004/07/01

The increasing number of patents on minute and obscure aspects of pharmaceutical products is fast becoming the principle obstacle facing the industry. This not only keeps the cost of medicines unnecessarily high, but more worryingly, it eliminates the stimulus to discover new cures for life-threatening illnesses.

2004/06/03

Rory O’Riordan, president of EGA, called for the creation of an EU equivalent to the United States National Institutes of Health (NIH) to ensure adequate funding for European research into the development of new pharmaceutical products.

2004/05/14

Celebrating its five-year anniversary, the Business Humanitarian Forum offers its first Business Humanitarian Award to Rory O’Riordan, President of the European Generic medicines Association (EGA).

2004/03/25

EGA Board of Directors urges early implementation of “Bolar provision” for Generics to ensure the future of European Research & Development.

2004/03/22

EGA Welcomes Clarification on the European Reference Product from the European Commission.

2004/03/10

European Reference Product Needs Rapid Implementation.

2004/03/09

Statement on the Vote in the European Parliament on the IP Enforcement Directive.

2004/03/08

Dangers to Affordable Healthcare in IP Enforcement Directive: “Safeguard Amendment” Needed in Fourtou Report.

2004/02/09

Precise and Rapid Implementation of New EU Pharmaceutical Legislation is “Top of the Agenda” for EGA Regulatory Affairs Conference.

The EGA

“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.”

The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.

The EGA represents over 500 companies and their subsidiaries from greater Europe, and over 100,000 jobs. Generic medicines save €18 billion each year for health care systems and patients.

For further information: